What is the share price of Zydus Healthcare Ltd (GERMANREM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Zydus Healthcare Ltd (GERMANREM) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Zydus Healthcare?

The latest standalone P/E ratio of Zydus Healthcare as of 01-Jan-1970 is 0.56.

What is the P/B ratio of Zydus Healthcare Ltd (GERMANREM)?

The latest standalone P/B ratio of Zydus Healthcare Ltd (GERMANREM) as of 01-Jan-1970 is 47.32.

What is the 52-week high and low of Zydus Healthcare Ltd (GERMANREM)?

The 52-week high of Zydus Healthcare Ltd (GERMANREM) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Zydus Healthcare Ltd (GERMANREM) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Zydus Healthcare Ltd (GERMANREM)
Brand: Zydus Healthcare

Zydus Healthcare Ltd (GERMANREM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500156 NSE: GERMANREM Pharmaceuticals & Drugs | Small Cap | Zydus Healthcare Share Price

Zydus Healthcare Ltd (GERMANREM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500156 NSE: GERMANREM Pharmaceuticals & Drugs | Small Cap | Zydus Healthcare Share Price

Key Metrics

Valuation Multiples

Market Cap

₹390 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹845.8

TTM Sales

₹3,472 Cr.

Book Value per Share

₹10

P/E Ratio

0.56

Industry PE

46.6

Price to Book (P/B)

47.32

Price to Sales (P/S)

0.11

EV/EBITDA

-0.01

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

18.31%

Return on Capital Employed (ROCE)

21.54%

Return on Assets (ROA)

14.57%

Operating Profit Margin

36.9%

Net Profit Margin

25.94%

Gross Profit Margin

44.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

5.61%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

22.21%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

24.7%

Asset Quality

Promoter Holding

100.00%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

Equity

₹8.3 Cr.

Face Value

₹10

All Time Low / High

₹194.45 / 1390.00

Zydus Healthcare stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	1%	4%	3.6%	7.2%	6.5%	10.1%	16.3%	14.9%	17.3%	21.5%	-
Value Creation Index ⓘ	-0.9	-0.7	-0.7	-0.5	-0.5	-0.3	0.2	0.1	0.2	0.5	-
Growth Parameters ⓘ
Sales ⓘ	163	2,812	2,971	3,129	2,867	3,182	3,472	3,651	3,877	4,095	3,472
Sales YoY Gr.	-	1,629.5%	5.7%	5.3%	-8.4%	11%	9.1%	5.2%	6.2%	5.6%	-
Adj EPS ⓘ	541.7	520.8	416.7	794.1	855	1,048.2	2,825.9	3,325.9	3,890.7	4,866.2	845.8
YoY Gr.	-	-3.9%	-20%	90.6%	7.7%	22.6%	169.6%	17.7%	17%	25.1%	-
BVPS (₹) ⓘ	3,780	20,087.1	20,897.2	19,855.3	16,607.4	17,638.7	20,862.2	23,437.3	24,949.3	28,514.8	10
Adj Net Profit ⓘ	2.6	101	90.1	172	185	227	611	719	841	1,052	698
Cash Flow from Ops. ⓘ	45.9	510	637	732	1,010	914	1,075	1,114	1,116	1,198	-
Debt/CF from Ops. ⓘ	10.5	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	43.1%	7.4%	5.7%	5.6%
Adj EPS ⓘ	27.6%	41.6%	19.9%	25.1%
BVPSⓘ	25.2%	11.4%	11%	14.3%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.1	1.9	1.6	3.1	3.7	4.8	13.1	15	16	18.1	5.9
Op. Profit Mgn % ⓘ	58.4	25.6	25.2	29.5	28.4	31	33	31.4	31.9	36.9	0
Net Profit Mgn % ⓘ	1.6	3.6	3	5.5	6.5	7.1	17.6	19.7	21.7	25.7	20.1
Debt to Equity ⓘ	25.6	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	668	106	143	165	198	228	250	304	413	489	0
Cash Conv. Cycle ⓘ	147	15	13	7	15	9	9	7	5	6	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	162.60	2,812.10	2,971.40	3,129	2,866.90	3,181.90	3,472	3,651.20	3,899.50	4,094.60
Operating Expenses ⓘ +	67.70	2,092.40	2,222.90	2,207.60	2,052.60	2,194.60	2,326.90	2,508	2,664.70	2,585.50
Manufacturing Costs	8.30	291.80	191.60	235.60	337.30	351.80	402.30	376.80	403	376
Material Costs	15	884.80	1,060.80	705.20	617.40	738.20	782.50	814	825.90	641.30
Employee Cost	2.20	437.70	476.20	515	588.20	622.40	644.20	736.20	737.90	796.60
Other Costs ⓘ	42.20	478.10	494.30	751.80	509.70	482.20	497.90	581	697.90	771.60
Operating Profit ⓘ	94.90	719.70	748.50	921.40	814.30	987.30	1,145.10	1,143.20	1,234.80	1,509.10
Operating Profit Margin (%)	58.4%	25.6%	25.2%	29.4%	28.4%	31.0%	33.0%	31.3%	31.7%	36.9%
Other Income ⓘ +	0.10	2.90	13.60	41	74.80	61.40	79.60	146.30	243.80	309.30
Exceptional Items ⓘ	0	0	0	0	0	0	112.70	0	0	0
Interest ⓘ	6.20	31.90	2.30	2.20	1.90	5.30	0.60	0.60	0.60	0.40
Depreciation ⓘ	68.20	502.20	553.30	561.90	566.60	569.20	574.90	575.20	572.60	568.80
Profit Before Tax ⓘ	20.60	188.50	206.50	398.30	320.60	474.20	761.90	713.70	905.40	1,249.20
Tax ⓘ	18	87.70	116.50	226.70	136.20	247.40	64.50	-15.50	53.70	187.10
Profit After Tax	2.60	100.80	90	171.60	184.40	226.80	697.40	729.20	851.70	1,062.10
PAT Margin (%)	1.6%	3.6%	3.0%	5.5%	6.4%	7.1%	20.1%	20.0%	21.8%	25.9%
Adjusted EPS (₹)	520.0	519.6	414.8	790.8	849.8	1,045.2	3,213.8	3,360.4	3,924.9	4,894.5
Dividend Payout Ratio (%)	365.40%	288.70%	259.20%	145.40%	1.80%	0%	0%	23.20%	59.90%	26.70%

Valuation of Zydus Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	18.90	5,133.40	5,771.20	5,315.10	4,610.30	4,834.10	4,527.10	5,085.90	5,414	6,187.70
Share Capital ⓘ	0.50	1,255.90	1,258.20	1,028.20	1,028.20	1,028.20	21.70	21.70	21.70	21.70
Reserves ⓘ	18.40	3,877.50	4,513	4,286.90	3,582.10	3,805.90	4,505.40	5,064.20	5,392.30	6,166
Debt +	483.40	20	20	0	0	0	0	0	0	0
Long Term Debt	33	20	20	0	0	0	0	0	0	0
Short Term Debt	450.40	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	84.60	418.20	465.50	398.20	400	492.50	536.70	455.90	463.20	461.20
Others Liabilities ⓘ	4,793.80	705.10	290	207.50	580.40	820.90	861.10	871.50	964.70	1,092.40
Total Liabilities ⓘ	5,380.70	6,276.70	6,546.70	5,920.80	5,590.70	6,147.50	5,924.90	6,413.30	6,841.90	7,741.30
Fixed Assets
Net Fixed Assets ⓘ +	4,728.90	5,113.90	4,678.60	4,239.60	3,711.10	3,208.30	2,662.90	2,111.60	1,579.90	1,040.90
Gross Block	4,798.10	5,684.90	5,803.20	5,925.80	5,962.90	6,027.60	6,054.80	6,076.50	6,115.40	6,142.60
Accumulated Depreciation	69.20	571	1,124.60	1,686.20	2,251.80	2,819.30	3,391.90	3,964.90	4,535.50	5,101.70
CWIP ⓘ	0.70	60.50	61	18.70	3.40	5.10	0.80	1.10	10.40	35
Investments ⓘ	0.90	1.80	104.40	92.80	188.80	365.50	531.70	469.60	217.10	402.50
Inventories	134.30	314.20	374	370.30	375.50	466.30	531.20	425.50	380.70	452
Trade Receivables	137.70	266.50	301.50	286.70	178	220.50	253.20	268.30	297.60	337.80
Cash Equivalents	23.60	20.40	432.60	12.70	130.10	144.70	398.60	20.70	24.80	307
Others Assets ⓘ	354.60	499.40	594.60	900	1,003.80	1,737.10	1,546.50	3,116.50	4,331.40	5,166.10
Total Assets ⓘ	5,380.70	6,276.70	6,546.70	5,920.80	5,590.70	6,147.50	5,924.90	6,413.30	6,841.90	7,741.30

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	45.90	510.40	636.80	731.50	1,010.10	914.10	1,074.50	1,114.30	1,116.40	1,197.80
PBT ⓘ	20.60	188.50	206.50	398.30	320.60	474.20	761.90	713.70	905.40	1,249.20
Adjustment ⓘ	74.30	539.60	552.60	524.50	525.30	618.90	440.20	411.80	334.60	298.50
Changes in Working Capital ⓘ	-9.1	-180.6	-91.1	-87.1	249.2	-101.4	43.2	105.7	37.4	-172.5
Tax Paid ⓘ	-39.90	-37.10	-31.20	-104.20	-85	-77.60	-170.80	-116.90	-161	-177.40
Cash Flow From Investing Activity ⓘ +	-56.80	-904.20	-112.40	-424.80	-186.50	-811.50	186.90	-1,034.60	-602	-883.60
Capex	-60.90	-906.90	-110	-73.90	-22.20	-65.40	90.90	-26.80	-61.10	-45.80
Net Investments	4	0	0	9.20	-175.70	-38.60	-153.90	368.20	260.20	-416.80
Others ⓘ	0.10	2.70	-2.40	-360.10	11.40	-707.50	249.90	-1,376	-801.10	-421
Cash Flow From Financing Activity ⓘ +	18.30	369.70	-11.50	-638.10	-820.20	-21.40	-1,007.50	-169	-508.80	-282.90
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	-13	0	-6.90	0	-13.20	0	0	0	0
Interest Paid ⓘ	-2.70	-37.10	-2.30	-1.80	-0.90	-4.90	0	0	0	0
Dividend Paid ⓘ	-15.30	-300.30	-5.10	-331.30	-679.60	-3.30	0	-168.60	-508	-282.10
Others ⓘ	36.30	720.10	-4.10	-298.10	-139.70	0	-1,007.50	-0.40	-0.80	-0.80
Net Cash Flow ⓘ	7.40	-24.10	512.90	-331.40	3.40	81.20	253.90	-89.30	5.60	31.30

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	15.9	5.15	2.13	3.88	4.66	6.1	16.69	15.17	16.22	18.31
ROCE (%)	1.03	4.04	3.63	7.2	6.48	10.14	16.29	14.86	17.26	21.54
Asset Turnover Ratio	0.06	0.5	0.47	0.5	0.5	0.54	0.58	0.6	0.59	0.56
PAT to CFO Conversion(x)	17.65	5.06	7.08	4.26	5.48	4.03	1.54	1.53	1.31	1.13
Working Capital Days
Receivable Days	293.80	25.20	34.60	34.30	29.60	22.90	24.90	25.90	26.50	28.30
Inventory Days	286.50	27.90	41.90	43.40	47.50	48.30	52.40	47.40	37.70	37.10
Payable Days	1,029.30	103.70	152	223.50	235.90	220.70	240	222.50	203.10	263.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zydus Healthcare Ltd FAQs

The current trading price of Zydus Healthcare on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zydus Healthcare stood at ₹390.2 Cr

The latest P/E ratio of Zydus Healthcare as of 31-Dec-1969 is 0.56.

The latest P/B ratio of Zydus Healthcare as of 31-Dec-1969 is 47.32.

The 52-week high of Zydus Healthcare is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Healthcare is ₹3,472 ( Cr.) .

Data is not available for this company.

No data found

About Zydus Healthcare Ltd

No data to display

Zydus Healthcare Ltd (GERMANREM)

Zydus Healthcare Ltd (GERMANREM)

Zydus Healthcare stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zydus Healthcare - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zydus Healthcare Ltd FAQs

About Zydus Healthcare Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Zydus Healthcare Ltd (GERMANREM)

Zydus Healthcare Ltd (GERMANREM)

Zydus Healthcare stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zydus Healthcare - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zydus Healthcare Ltd FAQs

What is the share price of Zydus Healthcare?

What is the market cap of Zydus Healthcare?

What is the P/E ratio of Zydus Healthcare?

What is the P/B ratio of Zydus Healthcare?

What is the 52-week high and low of Zydus Healthcare?

What is the TTM revenue of Zydus Healthcare?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Zydus Healthcare Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.